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Optimal tuning of enzyme signaling is critical for
cellular homeostasis. We use fluorescence reso-
nance energy transfer reporters in live cells to follow
conformational transitions that tune the affinity of a
multidomain signal transducer, protein kinase C
(PKC), for optimal response to second messengers.
This enzyme comprises two diacylglycerol sensors,
the C1A and C1B domains, that have a sufficiently
high intrinsic affinity for ligand so that the enzyme
would be in a ligand-engaged, active state if not for
mechanisms that mask its domains. We show that
both diacylglycerol sensors are exposed in newly
synthesized PKC and that conformational transitions
following priming phosphorylations mask the do-
mains so that the lower affinity sensor, the C1B
domain, is the primary diacylglycerol binder. The
conformational rearrangements of PKC serve as a
paradigm for how multimodule transducers optimize
their dynamic range of signaling.
INTRODUCTION
The use ofmodules to build recognition in signal transducing pro-
teins is at the crux of signaling networks (Pawson, 1995, 2007).
The serine/threonine kinase, protein kinase C (PKC), epitomizes
the use of multiple modules to effectively respond to second
messengers. Intramolecular interactions control both the acces-
sibility of the active site to substrate and of the regulatory mod-
ules to the second messengers (Oancea and Meyer, 1998; Orr
andNewton, 1994; Stensman andLarsson, 2007). PKC isozymes
are critical in processing signals that drive cellular functions such
as proliferation, apoptosis, and differentiation (Griner and Kaza-
nietz, 2007;Newton, 2010).Correctly tuningPKCoutput is essen-
tial for cellular homeostasis and, as such, its dysregulation is
associated with a myriad of diseases, including cancer, meta-
bolic disorders, and neurodegeneration. Key to regulation of
the signaling output of most PKC isozymes is the ability of cyto-
solic enzyme to respond to the membrane-embedded lipid sec-Chemistry & Biology 21,ond messenger, diacylglycerol (DAG), in a dynamic range that
prevents signaling in the absence of agonists but allows efficient
signaling in response to small changes in DAG.
PKC isozymes are classified based on their membrane-target-
ing domains (Newton, 2010). cPKCs (Figure 1A; PKCa, PKCb,
and PKCg) contain tandemC1 domains (cysteine-rich zinc finger
domains) that bind DAG or their functional analogs, phorbol
esters (Sharkey et al., 1984), and a C2 domain that requires
phosphatidylinositol-4,5-bisphosphate (PIP2) as well as phos-
phatidylserine for Ca2+-dependent plasma membrane targeting
(Corbala´n-Garcı´a et al., 2003; Corbin et al., 2007; Evans et al.,
2006; Ko¨nig et al., 1985a). Novel PKC (nPKC) isozymes (PKCd,
PKCε, PKCh, and PKCq) also have tandem C1 domains, but
lack a functional C2 domain (Cho and Stahelin, 2006). nPKCs
efficiently respond to DAG production without the need for
Ca2+-dependent pretargeting to the plasma membrane because
their affinity for DAG is almost two orders of magnitude higher
than that of conventional PKCs (cPKCs). The C2 domains of
the novel PKCd and PKCq bind proteins containing phosphotyr-
osine, which for PKCq is an activating event (Benes et al., 2005;
Stahelin et al., 2012). Atypical PKCs (PKCi/l and PKCz) respond
to neither Ca2+ nor DAG, and protein scaffold interactions likely
regulate their function (Kazanietz et al., 1994).
When first synthesized, PKC is in an open conformation, with
its autoinhibitory pseudosubstrate out of the substrate-binding
cavity (Dutil and Newton, 2000). This species of PKC is
membrane-associated (Borner et al., 1989; Sonnenburg et al.,
2001), but inactive. Catalytic competence requires maturation
of PKC by ordered phosphorylation at three highly conserved
sites: the activation loop, the turn motif, and hydrophobic motif
(Newton, 2003). The first phosphorylation occurs at the activa-
tion loop by phosphoinositide-dependent kinase-1 and positions
the active site for catalysis (Dutil et al., 1998; Grodsky et al.,
2006; Le Good et al., 1998). This phosphorylation triggers phos-
phorylation at the turn motif, which anchors the C-terminal tail
onto the N lobe of the kinase, conferring stability (Hauge et al.,
2007). Turn motif phosphorylation, which is necessary for
catalytic function, triggers intramolecular autophosphorylation
of the hydrophobic motif (Behn-Krappa and Newton, 1999;
Edwards et al., 1999). Phosphorylation at this site is not required
for activity but helps align the aC helix of the kinase domain for
catalysis and thus supports optimal activity and stability (Gao
et al., 2008; Yang et al., 2002). Processing by phosphorylation459–469, April 24, 2014 ª2014 Elsevier Ltd All rights reserved 459
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Figure 1. Maturation of PKC Retards Agonist-Dependent Membrane Translocation Kinetics
(A) Schematic of cPKCs and nPKCs showing domain composition with the C1A and C1B domains (orange) and the C2 domain (yellow). The W and Y are the Trp
and Tyr residues at position 22 within the C1A (W58 in PKCbII) or C1B (Y123 in PKCbII) domains of cPKCs that dictate membrane affinity. nPKCs contain Trp at
both of these sites. The kinase domain (cyan) and the three priming phosphorylations are shown: the activation loop, turn motif, and hydrophobic motif.
(B) Ribbon structure of the kinase domain of PKCbII (Protein Data Bank [PDB] ID 2I0E) showing the three priming phosphorylations in stick form (Thr500, activation
loop; Thr641, turn motif; and Ser600, hydrophobic motif) and the kinase-inactivating mutations (Lys371 and AspD466 in the active site and Pro616 and Pro619 in
the PXXP motif) in ball form.
(C) Representative images displaying localization of the indicated YFP- and RFP-tagged PKCs, cotransfected into COS7 cells, before (top), after 2.5 min (middle),
or after 12.5 min (bottom) of PDBu treatment are shown.
(D) Western blot displaying whole-cell lysates of COS7 cells transfected with the indicated PKCbII constructs. The asterisk denotes the position of mature, fully
phosphorylated PKCbII, and the dash denotes the position of unphosphorylated PKCbII.
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Live Cell Imaging of PKC Conformational Changesdepends on a conserved PXXP motif (P616/P619 in PKCbII; Fig-
ure 1B) within PKC that binds the chaperone heat shock protein
90 (Gould et al., 2009); mutation of either of these Pro residues
results in a kinase that is not phosphorylated and is thus inactive.
Processing phosphorylations are also absent in other kinase-
inactive PKC mutants, presumably because autophosphoryla-
tion is prevented (Behn-Krappa and Newton, 1999). Last of
all, processing phosphorylations depend on the integrity of the
mTORC2 kinase complex by an unknown mechanism (Facchi-
netti et al., 2008; Ikenoue et al., 2008).
Mature PKC is released to the cytosol, where it adopts an auto-
inhibited conformation with the pseudosubstrate bound within
the substrate-binding site. Membrane engagement of the C1
and C2 domains of cPKCs, or just the C1 domain for nPKCs, in-
duces a conformational change that expels thepseudosubstrate,
activating PKC (Orr and Newton, 1994). Why PKC has two tan-
dem C1 domains is not clear considering that only one of the
C1 domains engages the membrane at a time (Kikkawa et al.,
1983; Ko¨nig et al., 1985b). Several studies have shown that for
the novel PKCd, the C1B domain is the predominant membrane
binding domain (Pu et al., 2009; Szallasi et al., 1996; Wu-Zhang
et al., 2012). However, it remains to be elucidated which C1
domain of PKCbII is the predominant membrane binder.460 Chemistry & Biology 21, 459–469, April 24, 2014 ª2014 ElsevierHerewe use fluorescence energy transfer (FRET)-based imag-
ing to depict conformational transitions of cPKCs and nPKCs
in live cells. Using a PKC conformation reporter, Kinameleon,
we show that PKCbII undergoes conformational transitions as
it matures, becomes activated, and downregulated. In addition,
analysis of membrane translocation kinetics reveals that the
ligand-binding surface of the C1 domains of PKC becomes
masked during the maturation of the enzyme. This occurs
through intramolecular interactions and tunes the affinity of
mature PKC for an optimal response to second messengers.
This mechanism is commonly used by other enzymes to opti-
mize their dynamic range of signaling, and thus demonstration
of conformational rearrangements within PKC serves as a para-
digm for signaling by other multimodule transducers.
RESULTS
Maturation of cPKC Retards Agonist-Dependent
Membrane Translocation Kinetics
Wehave shown that the integrity of a PXXPmotif in PKCbII (P616/
P619) is required for the proper phosphorylation and folding
of PKC (Gould et al., 2009). In imaging studies co-expressing
PKCbII-RFP and PKCbII-P616A/P619A-YFP in the same cell, weLtd All rights reserved
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Live Cell Imaging of PKC Conformational Changesobserved that the kinase-dead PKC translocated to the plasma
membranemore rapidly than thewild-type in response to phorbol
dibutyrate (PDBu), aPKCagonist (Figure1C, left panels). Todeter-
minewhether this accelerated translocationwascausedby lackof
catalytic activity, we examined the translocation of two additional
constructs whose active site had been altered to inhibit catalysis
(Figure 1B). In PKCbII-K371R, the conserved Lys that coordinates
the a-b phosphates of ATP was mutated (Buechler et al., 1989;
Ohno et al., 1990) and in PKCbII-D466N, the conserved Asp that
serves as the catalytic base in the phosphorylation reaction was
mutated. This latter construct retains the ability to autophosphor-
ylate weakly but cannot phosphorylate substrates (Gould et al.,
2011; Shi et al., 2010). As observed for the PXXP mutant, both
catalytically impaired constructs fully translocated to plasma
membrane after 2.5 min of PDBu treatment, whereas the wild-
typeenzyme, in thesamecell,wasprimarily cytosolic and required
12.5min for membrane translocation (Figure 1B). All three kinase-
dead mutants were partially localized at the plasma membrane
prior to stimulation. Thus, impairing PKCbII activity by three inde-
pendentmechanisms resulted inpretargeting to theplasmamem-
brane and accelerated agonist-induced membrane translocation
compared to wild-type.
To assess whether phosphorylation per se or the ordered
conformation changes that accompany maturation caused the
delayed translocation kinetics of wild-type PKCbII, we evaluated
the phosphorylation state of the constructs used in the transloca-
tion assays. We took advantage of the mobility shift on western
blots induced by quantitative phosphorylation at the C-terminal
tail (Keranen et al., 1995). Under the conditions of our experi-
ments, PKCbII migrated predominantly (67%) as an upper
mobility band, reflecting phosphorylation at the two C-terminal
priming sites (Figure 1D, lane 1, asterisk); approximately one third
of the protein was not phosphorylated (lower band, dash). The ki-
nase-inactivemutants PKCbII-K371R and PKCbII-P616A/P619A
were completely unphosphorylated (Figure 1D, lanes 2 and 4). In
contrast to these kinase-dead PKC mutants, the PKCbII-D466N
showed equal amounts of phosphorylated (52%) and unphos-
phorylated (48%) species (Figure 1D, lane 3). Thus, the transloca-
tion kinetics of PKC were unrelated to the state of processing
phosphorylations: wild-type PKCbII, with 67% phosphorylated
species, and PKCbII-D466N, with 52% phosphorylated species,
translocated with significantly different kinetics. These data
reveal that the conformation of the kinase-impaired PKCbII-
D466N does not recapitulate the ordered conformational transi-
tions accompanying the maturation of wild-type PKC, despite
permissive phosphorylation. In summary, catalytically inactive
constructs of PKC have accelerated membrane translocation,
independently of their phosphorylation state.
Kinameleon: A Probe for Conformational Transitions of
PKC in Cells
One possibility for the accelerated membrane association of
kinase-inactive PKC compared with wild-type is that unprimed
PKC is in a different conformation than that of mature PKC. To
probe for conformational differences between these two spe-
cies, we engineered a FRET-based conformational reporter we
named Kinameleon (for the changing colors depending on
conformation). Kinameleon (Figure 2A) comprises a CFP and
YFP flanking the N and C termini, respectively, of wild-typeChemistry & Biology 21,PKCbII (Kinameleon-WT) or the kinase-inactive PKCbII-K371R
(Kinameleon-K371R). A similar approach has been used for
PKCd, and this construct was shown to behave like untagged
PKCd (Braun et al., 2005). When expressed in Madin-Darby
canine kidney (MDCK) cells, unphosphorylated, kinase-dead
Kinameleon-K371R, exhibited a significantly lower basal FRET
ratio thanmature, phosphorylated Kinameleon-WT, as illustrated
by the raw pseudocolor FRET ratio image (Figure 2B). After
15 min stimulation with PDBu, Kinameleon-WT translocated to
the plasma membrane and FRET increased further, consistent
with an additional conformational rearrangement upon activa-
tion. Following 12 hr PDBu treatment to promote dephos-
phorylation of PKC, FRET decreased to levels similar to those
of Kinameleon-K371R. Quantitation of the FRET ratios (FRET/
CFP) as a function of time revealed that the FRET ratio for Kina-
meleon-WT approached that of the unprimed Kinameleon-
K371R following 12 hr of PDBu stimulation (Figure 2C). The
FRET increase resulted, in part, from intermolecular FRET be-
tween Kinameleons concentrated at the plasma membrane;
however, this only accounted for a small portion of the increase
observed because control cells co-expressing YFP-PKCbII-YFP
and CFP-PKCbII-CFP displayed a more modest increase (Fig-
ure 2D; compare upper to lower panel). These data are consis-
tent with a model (Figure 2A) in which the N and C termini of
PKC are oriented for low FRET in unprimed PKC, re-orient to
yield intermediate FRET upon maturation of PKC, are reposi-
tioned for high FRET upon activation of PKC, and regain their
original orientation (low FRET) following dephosphorylation.
Translocation Kinetics of Isolated C1A-C1B Domains of
PKC Can Be Tuned by a Single Residue
We have shown that a Trp at position 22 within the C1A or C1B
domain (Figures 1B and 3A) confers an approximate two orders
of magnitude higher affinity for DAG than a Tyr at that position
(Dries et al., 2007). In cPKCs, Trp is present in the C1A (Trp 58;
high affinity for DAG) and Tyr in the C1B (Tyr 123; low affinity
for DAG). Here, we take advantage of this toggle to selectively
tune the affinity of the C1A and/or C1B domains within cPKCs
as a tool to differentiate between them. We monitored the rate
of translocation of the isolated C1A-C1B domain to membranes
as a function of whether Tyr or Trpwas present at position 22.We
used our previously developed DAG reporter (DAGR; Violin et al.,
2003) that contains the tandem C1A-C1B domain of PKCb
flanked by CFP and YFP. Translocation of this reporter to the
plasma membrane can be quantified by the increase in intermo-
lecular FRET from CFP to YFP as the DAGRs become concen-
trated at the membrane. In response to PDBu, the isolated
C1A-C1B domain translocated to the plasma membrane with a
half-time of 0.82 ± 0.02 min (Figure 3B). Reducing the C1A do-
main’s affinity for ligand by mutating Trp58 to a Tyr (C1A-C1B-
W58Y) resulted in a 5-fold reduction in the rate of translocation
of the C1A-C1B domain to the plasma membrane (t1/2 = 3.69 ±
0.04 min) compared to wild-type. This effect could be rescued
by increasing the affinity of theC1B domain for ligand: the double
mutant C1A-C1B-W58Y/Y123W displayed similar translocation
kinetics to wild-type. Increasing the C1B domain’s affinity for
ligand (C1A-C1B-Y123W), while leaving the high affinity of the
C1A domain unchanged, resulted in pretargeting of the domain
to the plasma membrane and Golgi (Dries et al., 2007). It was459–469, April 24, 2014 ª2014 Elsevier Ltd All rights reserved 461
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Figure 2. An Intramolecular FRET Reporter Reads Conformational Transitions of PKC in Live Cells
(A) Diagram of Kinameleon showing CFP on the N terminus and YFP on the C terminus of PKC; schematic of how very low FRET reflects an unprimed
conformation (upper panel), intermediate FRET reflects a mature (phosphorylated at the activation loop in pink, turn motif in orange, and hydrophobic motif in
green) but inactive conformation (middle panel), and high FRET reflects an active conformation (lower panel).
(B) Pseudocolor FRET ratio images (left) and localization (right) of MDCK cells transiently expressing Kinameleon-K371R (representing unprocessed PKC),
Kinameleon-WT (representing mature, phosphorylated, but inactive PKC), Kinameleon-WT after 15 min of PDBu treatment (representing mature, active PKC),
and Kinameleon-WT after 12 hr of PDBu treatment (representing dephosphorylated PKC), depict different PKC conformations.
(C) Quantitation of the FRET ratios ± SEM of Kinameleon-WT post-PDBu treatment of cells and of Kinameleon-K371R in the absence of PDBu treatment.
(D) Kinameleon expressed in MDCK cells and stimulated with 200 nM PDBu results in increased FRET, shown as a change in the FRET ratio (upper panel). The
increasing FRET change with higher expression levels (linear regression in red, with 95% confidence bands in green) indicates an intermolecular (concentration-
dependent) interaction. The non-zero y-intercept indicates an intramolecular (concentration-independent) interaction, consistent with a conformational
change upon translocation. In contrast, co-expression of CFP-PKCbII-CFP and YFP-PKCbII-YFP shows only an intermolecular interaction after 200 nM PDBu
(lower panel).
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Live Cell Imaging of PKC Conformational Changesshown that the Y123Wmutation does not perturb the structure of
the C1B domain (Stewart et al., 2011), indicating that the domain
is not pretargeted to membranes and unable to translocate
because it ismisfolded; rather, its intrinsic affinity for membranes
is so high that it likely binds basal levels of DAG. Moreover, the
isolated C1A-C1B domain has a relatively high affinity for phor-
bol esters because subsaturating levels of PDBu (50 nM) that
were insufficient to maximally translocate full-length PKCbII
(see Figure 4D) were sufficient to cause full translocation of the
C1A-C1B domain to the plasma membrane (Figure 3D). These
data are consistent with the C1A and C1B moieties of the
C1A-C1B module being fully accessible for membrane engage-
ment: Tyr at the toggle position of either domain reduces the rate
of translocation, whereas Trp at either position increases the rate
of translocation. Moreover, constructs with Tyr in onemoiety and
Trp in the other moiety have similar translocation kinetics, inde-
pendently of whether the Tyr is in the C1A or C1B.462 Chemistry & Biology 21, 459–469, April 24, 2014 ª2014 ElsevierUnprimed PKC Has an Exposed C1A-C1B Domain that Is
Masked upon Proper Maturation
Using FRET, we quantified the translocation kinetics of YFP-
tagged cPKCs toward plasma membrane-targeted CFP. PKCbII
translocated to the plasma membrane in response to PDBu with
significantly slower kinetics than the isolated C1A-C1B domain
(Figure 4A; t1/2 = 3.56 ± 0.02 min versus 0.82 ± 0.02 min). In
contrast, the unphosphorylated PKCbII-K371R and PKCbII-
P616A/P619A mutants translocated with rates that matched
those of the isolated C1A-C1B domain (t1/2 = 0.35 ± 0.07 min
and t1/2 = 0.63 ± 0.05 min, respectively). These data are consis-
tent with both C1A and C1B moieties being fully exposed in
these mutants, whereas one or the other (or both) becomes
masked in the properly primed wild-type PKCbII. PKCbII-
D466N (t1/2 = 0.53 ± 0.07 min) also translocated with kinetics
similar to those of the isolated C1A-C1B domain, suggesting that
even though approximately 52% of the pool of PKCbII-D466N isLtd All rights reserved
Figure 3. Translocation Kinetics of the Isolated C1A-C1B Domain of PKCbII Can Be Tuned by a Single Residue
(A) Ribbon structure of the C1B domain of PKCa (PDB ID 2ELI) showing the DAG affinity toggle, Tyr at position 22 in the domain (Tyr123 in PKCa and PKCb). This
residue is present as Trp (Trp58) in the C1A domain of PKCa and PKCb.
(B) COS7 cells transfected with the indicated C1A-C1B constructs flanked by CFP and YFPweremonitored for their intermolecular FRET ratio ± SEM upon PDBu
stimulation.
(C) Representative YFP images of the basal localization of wild-type or mutant C1A-C1B domains.
(D) Trace showing translocation kinetics of the C1A-C1B domain ± SEMwith subsaturating levels of phorbol esters (50 nMPDBu), followed by saturating amounts
of PDBu to yield a final concentration of 200 nM.
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Live Cell Imaging of PKC Conformational Changesphosphorylated, it is not properly folded. Next, we examined
whether the C1A-C1B domain of another cPKC, PKCa, was
also masked during maturation. The corresponding PKCa
kinase-dead mutant, PKCa-K368M, migrated as an unphos-
phorylated species on a PAGE gel (Figure 4B, lanes 2 and 4,
dash), whereas 52% of the pool of PKCa-D463N was phosphor-
ylated at the C-terminal sites (Figure 4B, compare lanes 1 and 3),
same as for PKCbII-D466N. Yet both of these kinase-dead PKCa
mutants (PKCa-K368M t1/2 = 0.82 ± 0.02 min; PKCa-D463N
t1/2 = 1.26 ± 0.01 min) responded more rapidly to PDBu than
wild-type (t1/2 = 9.18 ± 0.01 min; Figure 4C), showing that the
trend of fast translocation of kinase-dead PKCs is a common
phenomenon among cPKCs. These data corroborate that the
kinase-dead PKCbII-D466N and PKCa-D463N do not adopt
the conformation of the wild-type enzyme despite being partially
phosphorylated. Thus, cPKCs undergo a conformational change
upon proper PKC maturation, which masks the ligand-binding
surface of the C1A-C1B domain, leading to a slower transloca-
tion of primed PKC compared to unprocessed PKC or to the
isolated C1A-C1B domain.
As an additional measure of whether the C1A-C1B domain be-
comes masked upon maturation, we examined membrane bind-
ing induced by subsaturating concentrations of phorbol esters
(50 nM). Whereas the C1A-C1B domain fully translocated to
the plasma membrane upon addition of 50 nM PDBu, less than
50% of the pool of monitored full-length, wild-type PKCbII trans-
located (Figure 4C compared to Figure 3D). However, all the
kinase-dead PKCbIIs maximally translocated (Figure 3D), sug-
gesting that these unprimed or improperly primed mutants
have a lower threshold for PDBu activation resulting from fully
exposed ligand-binding surfaces on their C1A-C1B domains.
Both the C1A and C1B Domains of Unphosphorylated
PKC Are Exposed and Become Masked upon Priming
Conventional and novel PKCs have two functional C1 domains,
yet only one of the domains is engaged on the membrane at a
time (Giorgione et al., 2003; Kikkawa et al., 1983). To dissectChemistry & Biology 21,the respective contribution of each domain on driving transloca-
tion of PKCbII, we addressed the effect of altering the ligand
affinity of the C1A and C1B domains on ligand-dependent mem-
brane translocation. We first examined the phorbol ester-depen-
dent membrane translocation, and then the DAG-dependent
translocation (see below), because the differences in affinity for
these two ligands vary greatly between the domains. Specif-
ically, the affinity of the C1A domain for DAG is almost two orders
of magnitude higher than that of the C1B domain, whereas for
PDBu, the difference in affinity is only 6-fold (Dries et al., 2007).
To this end, we altered the affinity of the C1A or C1B domain
by mutating the residue at position 22 within full-length PKCbII.
A Trp to Tyr mutation in the C1A domain (PKCbII-W58Y) did
not affect translocation kinetics (Figure 5A), which is consistent
with the ligand-binding surface of the C1A domain being
occluded within primed PKCbII. In contrast, the translocation ki-
netics of the kinase-dead PKCbII-W58Y/K371R (Figure 5B; t1/2 =
1.38 ± 0.04 versus 0.35 ± 0.07 min) and PKCbII-W58Y/D466N
(Figure 5C; t1/2 = 1.55 ± 0.04 versus 0.52 ± 0.04 min) were sen-
sitive to mutation of the C1A domain, revealing that the C1A
domain is exposed in these mutants. To further show that this
single residue can dictate the translocation kinetics of full-length
kinase-dead PKC, we inverted the DAG affinities of the C1A
(from high to low) and C1B domains (from low to high) in a kinase
inactive construct. This PKCbII-W58Y/Y123W/D466N mutant
translocated with similar kinetics to those of PKCbII-D466N (Fig-
ure 5C; t1/2 = 0.49 ± 0.06 min versus 0.52 ± 0.04 min), supporting
the finding that both domains are exposed in this improperly pro-
cessed PKC and revealing that these mutations do not affect the
folding of the C1 domains. Moreover, these results show that it
does not matter whether the higher affinity domain is positioned
before or after the lower affinity domain. Curiously, the PKCbII-
W58Y/P616A/P619A (0.71 ± 0.03 min) mutant did not display
slower kinetics of translocation than PKCbII-P616A/P619A
(0.63 ± 0.05 min; Figure 5D), suggesting that this mutant may
be folded differently from the other kinase-inactive ones. These
data reveal that the ligand-binding surface of both C1A and459–469, April 24, 2014 ª2014 Elsevier Ltd All rights reserved 463
Figure 4. Unprimed cPKCs Have an Exposed C1A-C1B Tandem
Module that Is Masked upon Maturation
(A) The FRET ratios of COS7 cells cotransfected with membrane-targeted CFP
and the indicated full-length, YFP-tagged PKCbII constructs were monitored
upon PDBu treatment. Plots show data normalized to 100% for the maximal
FRET response ± SEM.
(B) Western blot of whole-cell lysates of COS7 cells transfected with the
indicated HA-PKCa constructs. The asterisk denotes the position of mature,
fully phosphorylated PKCa, and the dash denotes the position of un-
phosphorylated PKCa.
(C) FRET ratios ± SEM of COS7 cells cotransfected with membrane-targeted
CFP and the indicated full-length, YFP-tagged PKCa constructs were moni-
tored upon PDBu stimulation.
(D) FRET ratios ± SEM of COS7 cells cotransfected with membrane-targeted
CFP and the indicated full-length, YFP-tagged PKCbII constructs were
monitored upon stimulation with a subsaturating PDBu concentration for wild-
type PKCbII (50 nM), followed by treatment with another 150 nM PDBu to
evoke a maximal response.
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Live Cell Imaging of PKC Conformational ChangesC1Bdomains are exposed in unprocessedPKC and that theC1A
domain becomes occluded during maturation.
We next addressed whether the C1B domain is exposed in
matured PKCbII. There was no difference between PKCbII and
PKCbII-Y123W (Figure 5A), indicating that the ligand-binding
surface of the C1B domain is also masked in the fully matured
PKC. However, the C1B domain is fully exposed in the kinase-
dead mutants, as evidenced by the mutants constitutive associ-
ation with the plasma membrane and the Golgi (Figure 5E, top
panels), similar to the C1A-C1B-Y123W domain mutant (Fig-
ure 3C). These mutants displayed no further translocation to
the plasma membrane with PDBu treatment (Figure 5E, bottom
panels).
To further validate that both the C1A and C1B domains are
exposed in unprocessed PKC, we examined the effect of
preventing processing of the novel PKCd, which contains two
high-affinity C1 domains because it has Trp at position 22 in
both domains (Figure 1A). The kinase-dead PKCd-K376R and
PKCd-D471N were constitutively associated with the plasma464 Chemistry & Biology 21, 459–469, April 24, 2014 ª2014 Elseviermembrane and Golgi (Figure 5E), consistent with exposure of
two high-affinity DAG binders causing constitutive membrane
interaction. These data reveal that unprimed mutants of both
cPKCs and nPKCs have exposed ligand-binding surfaces in
their C1A and C1B domains and that these surfaces become
occluded through intramolecular conformational changes as
PKC matures.
Both the C1A and C1B Domains Are Involved in
Membrane Binding, but the C1B Domain Dominates
The insensitivity of mature PKC toward changes in ligand affinity
of the C1A or C1B domain toward PDBu could reflect the use of
saturating concentrations of this potent ligand, so that 6-fold dif-
ferences in ligand affinity between Trp versus Tyr at position 22
might be undetectable. To address this, we used a much lower
affinity ligand, DAG, to test whether stimulation with subsaturat-
ing levels of the synthetic DAG, 1,2-dioctanoyl-sn-glycerol
(DiC8) could reveal a difference between PKCbII and PKCbII in
which the affinity of either the C1A or C1B domain has been
altered. Modifying the affinity of either the C1A or C1B domain
altered the steady-state levels of PKCbII bound to the DiC8-con-
taining plasma membrane (and thus the amplitude of transloca-
tion); decreasing the affinity of the C1A domain (PKCbII-W58Y)
lowered the amplitude of translocation by 13%, whereas
increasing the affinity of the C1B domain (PKCbII-Y123W)
increased the amplitude by 20% (Figure 6). In comparison, the
unprimed PKCbII-D466N mutant translocated maximally and
with much faster kinetics than wild-type enzyme upon DiC8
treatment, reflecting two highly exposed C1 domains. These
data further support that properly primed PKCbII has its
ligand-binding surfaces on both its C1A and C1B domains
masked and that the improperly primed PKCbII-D466Nmutant’s
translocation does not mimic that of WT PKCbII.
DISCUSSION
Here we use genetically encoded reporters to show that matura-
tion of PKCbII by phosphorylation triggers conformational
changes that set the ligand affinity of the enzyme for optimal
signaling. The paradigm of intramolecular interactions tuning
the ligand binding affinity to increase the dynamic range of a
signaling molecule is used by numerous multidomain enzymes.
For example, the Src family of tyrosine kinases displays intramo-
lecular interactions between its kinase domain and its phospho-
Tyr binding SH2 domain and PXXP-recognizing SH3 domain
to maintain the kinase in an inactive conformation (Boggon and
Eck, 2004; Hof et al., 1998). In this case, the enzyme’s affinity
for its domains is sufficiently low to allow intermolecular ligands
to effectively compete and permit signal transduction. Similarly,
intramolecular interactions of the PH and Ras-association do-
mains of the Rap1-interacting adaptor molecule restrain their
ability to bind membranes (Wynne et al., 2012). This also seems
to be the case for the PH domain of Akt (Astoul et al., 1999),
consistent with intramolecular interactions lowering the affinity
of its PH domain for membranes to optimize its signaling.
Extensive studies have established that PKC is matured by
phosphorylation, but the role of phosphorylation in structuring
the enzyme for signaling is not known. Partial crystal structures
of PKC have been solved (Grodsky et al., 2006; Guerrero-ValeroLtd All rights reserved
Figure 5. Both the C1A and C1B Domains of Unphosphorylated PKCs Are Exposed and Become Masked upon Priming of PKC
(A–D) FRET ratios ± SEM of COS7 cells cotransfected with membrane-targeted CFP and the indicated full-length, YFP-tagged PKCbII constructs weremonitored
upon PDBu treatment.
(E) Representative YFP images of localization of the indicated PKCbII or PKCd mutants before (top) or after (bottom) PDBu treatment.
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information exists on conformational rearrangements. Using
Kinameleon, we show that unprocessed PKC and PKC that
has been dephosphorylated following prolonged activation are
both in an open conformation that is distinct from the closed
conformation ofmature, but inactive, PKC. Analysis of transloca-
tion kinetics reveals that the ligand-binding surfaces of the C1A
and C1B domains are fully exposed in this open conformation
but become masked upon maturation by phosphorylation. Our
data are consistent with the partial PKCbII structure, which
shows that phosphorylation anchors the carboxyl-terminal tail
of PKC onto the top of its N lobe where it interacts with the
C1B domain (Leonard et al., 2011), preventing this domain
from easily accessing DAG. Our data also corroborate work
from Stensman and colleagues showing that the membrane
translocation of kinase-dead PKCa-K368M is much more sensi-
tive to DAG than wild-type PKCa (Stensman et al., 2004). They
propose that only the C1A domain of PKCa is masked through
intramolecular interaction between the C-terminal tail and the
C2 domain (Stensman and Larsson, 2007), whereas our data
are more consistent with both C1A and C1B domains of PKCbII
becomingmasked. Thismasking of the C1 domains likely occurs
in all cPKCs and some of the nPKCs; the C1 domains of PKCg
were also shown to be occluded in the full-length proteinChemistry & Biology 21,(Oancea and Meyer, 1998) and here we show PKCd’s C1 do-
mains are also masked, consistent with results of a previous
study (Stahelin et al., 2004). We also demonstrate that species
of PKCwith impaired catalytic activity remain in the open confor-
mation regardless of phosphorylation status—although half of
the pool of PKCbII-D466N or PKCa-D463N is phosphorylated,
the translocation kinetics of these kinase-deadmutants are iden-
tical to those of the isolated C1A-C1B domain, not those of wild-
type PKC, suggesting that these kinase-inactive PKCs are not
folded like wild-type PKC. We note caution should be taken
when using kinase-dead mutants because they do not provide
the same scaffolding structure as wild-type, their translocation
is much more sensitive to DAG, and, in the case of nPKCs,
they are localized differently from wild-type, a finding consistent
with previous work (Guo et al., 2010). It is also noteworthy that
gross overexpression of PKC allows a pool of PKC to remain un-
processed and thus more readily associate with membranes. In
summary, our data are consistent with a model in which phos-
phorylation triggers a series of ordered conformational transi-
tions, via a mechanism that requires the intrinsic catalytic activity
of PKC, that masks the C1 domains so that the lower affinity DAG
sensor, the C1B domain, is used for PKCbII.
The stoichiometry of ligand binding of full-length PKC is 1mole
DAG/phorbol ester per 1 mole PKC (Kikkawa et al., 1983; Ko¨nig459–469, April 24, 2014 ª2014 Elsevier Ltd All rights reserved 465
Figure 6. The C1A and C1B Domains Are Involved in Membrane
Binding, but the C1B Domain Dominates
The FRET ratios ± SEM of COS7 cells cotransfected with membrane-targeted
CFP and the indicated full-length, YFP-tagged PKCbII constructs were
monitored upon stimulation with the PKC agonists DiC8 and PDBu.
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no cooperativity in binding DAG (Hill coefficient = 1), as would
be expected from the reduction in dimensionality of engaging
the second C1 domain once the first one has engaged on the
membrane (Hannun and Bell, 1986; Mosior and Newton, 1998;
Newton and Koshland, 1989). Yet whether the C1A or C1B
dominates as the DAG sensor in PKCbII has not been well estab-
lished. To distinguish between the contributions of these do-
mains, we engineered PKCbII mutants in which we toggled the
affinity of each C1 domain for ligand. Inverting the affinities of
the C1A and C1B domains for ligand had no apparent effect
on PDBu-induced PKC translocation rates (Figure 5A), likely
because this switch has amodest effect on phorbol ester binding
and because saturating concentrations of PDBu were used.
Importantly, stimulation with subsaturating levels of DAG, which
exhibits an approximate two orders of magnitude higher affinity
for the C1A versus C1B domain (Dries et al., 2007), uncovered a
difference (Figure 6). Decreasing the affinity of the C1A domain
for ligand lowered the steady-state levels of PKCbII bound to
the plasma membrane, whereas increasing the affinity of the
C1B domain increased the steady-state levels bound to the
membrane, suggesting that both domains can be involved in
membrane binding. The altered membrane affinities are likely
caused by changes in the membrane dissociation rate, because
we have shown that mutants with lower affinities for DAG have
increased membrane dissociation rate constants (Dries and
Newton, 2008). However, reducing the affinity of the C1A domain
for DAG by approximately 100-fold only decreased steady-state
binding by 2-fold. If this were the dominant binding domain, the
steady-state levels should have decreased by at least an order of
magnitude more. This suggests that the C1B is the predominant
binding domain for PKCbII. Here, increasing themembrane affin-
ity by 100-fold increased steady-state levels also by 2-fold; this
is less than expected but consistent with the C1B domain being
masked in the full-length wild-type enzyme. Moreover, our data
show that the C1A and C1B domains are exposed in kinase-
dead PKCs, because toggling the affinity of either domain had
a significant effect on their translocation kinetics.466 Chemistry & Biology 21, 459–469, April 24, 2014 ª2014 ElsevierBased on these studies on PKC conformation, we build on the
model for PKC maturation (Figure 7). We propose that unprimed
PKC is in an open conformation that associates with membranes
(Sonnenburg et al., 2001) through weak interactions with the
pseudosubstrate (Mosior and McLaughlin, 1991), C1 and C2
domains (Johnson et al., 2000), andC-terminal tail (Yang and Igu-
menova, 2013). Both theC1A andC1Bdomains are exposed and
the pseudosubstrate is out of the active site (Dutil and Newton,
2000; Johnson et al., 2000; Figure 7A). Upon ordered phos-
phorylation of PKC at its three priming sites, PKC matures into
its closed conformation in which the ligand-binding surface
of both the C1A and C1B domains becomes masked and
the pseudosubstrate occupies the substrate-binding cavity
(Figure 7B). Thus, PKCs are maintained in an inactive, closed
conformation by intramolecular interactions induced by phos-
phorylation. Upon activation, cPKCs translocate to membranes
by a two-step mechanism (Nalefski and Newton, 2001): first,
binding of Ca2+ to the C2 domain mediates its binding to the
membrane through electrostatic and hydrophobic interactions
(Scott et al., 2013; Figure 7C). Because the C2 domain of cPKC
has a high affinity for PIP2, which is enriched within the plasma
membrane compared to other membranes, cPKCs preferentially
translocate to this membrane (Evans et al., 2006; Ferrer-Orta
et al., 2009; Guerrero-Valero et al., 2009; Marı´n-Vicente et al.,
2005). Engagement of the C2 domain in the membrane not only
reduces the dimensionality of the C1A or C1B domain search
forDAG,but also leads to intramolecular conformational changes
(Stahelin and Cho, 2001) that allow the C1A and C1B domains to
become slightly more exposed (Bittova et al., 2001). Second,
binding of either the C1A or the C1B domain, but predominantly
the C1B domain for PKCbII (Figure 7D), to DAG expels the pseu-
dosubstrate and activates PKC. Use of this lower affinity C1B
domain as the primary membrane localization module for cPKCs
allows PKC to respond accordingly to a wider range of DAG
levels at the plasma membrane. Upon activation, PKC is quickly
dephosphorylated and thus transitions back to its exposed
(open) conformation of unprimed PKC (Figure 7E).
In summary, our data reveal an elegant mechanism by which
intramolecular conformational transitions tune the affinity of
mature PKC for its allosteric activator, DAG, as a regulatory
mechanism to allow ultrasensitivity in the signaling output of
PKC.We have previously shown that the binding of PKC tomem-
branes displays high cooperativity with respect to phosphatidyl-
serine (Newton and Koshland, 1989; Orr and Newton, 1992).
Thus, by reducing the affinity of both conventional and
novel PKCs for membranes through conformational transitions
induced during maturation, basal signaling of these isozymes
is minimized. Indeed, without this masking by maturation,
isozymes such as the novel PKCd that has two high-affinity C1
domains would be constitutively pretargeted to the plasma
membrane and the Golgi; for these isozymes, masking of the
C1 domains is necessary to prevent constitutive association of
PKC with membranes and thus constitutive activity. The mature
enzyme conformation does, however, enable PKCs to respond
effectively to very small changes in DAG. Moreover, basal
signaling of PKCbII is further attenuated through the preferential
use of the lower affinity DAG sensor, the C1B domain, which
allows cPKCs to signal at different membranes from nPKCs.
The affinity of the C1B domain for DAG is too low to allow cPKCsLtd All rights reserved
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Figure 7. Model Showing How Maturation
of cPKC Masks C1 Domains to Increase
the Dynamic Range of DAG Sensing and
thus PKC Output
(A) Unprimed PKC is in an open conformation that
associates with membranes via weak interactions
from the C2 domain, both C1A and C1B domains,
the exposed pseudosubstrate, and the C-terminal
tail. In this conformation, both C1A and C1B
domains are fully exposed.
(B) Upon ordered phosphorylation of PKC at
its activation loop (pink), turn motif (orange), and
hydrophobic motif (green) sites, PKC matures
into its closed conformation, in which both the
C1A and C1B domains become masked, the
pseudosubstrate binds the substrate binding
site, and the enzyme localizes to the cytosol. This
masking of the C1 domains prevents pretargeting
of PKC to membranes in the absence of agonist-
evoked increases in DAG, thus decreasing basal
signaling.
(C) In response to agonists that promote PIP2 hydrolysis, Ca
2+-dependent binding of the C2 domain of cPKCs to the plasma membrane allows the low-affinity
DAG sensor to find its membrane-embedded ligand, DAG.
(D) Binding of DAG, predominantly to the C1B domain of PKCbII, expels the pseudosubstrate from the substrate-binding cavity and activates PKC. Use primarily
of the lower-affinity C1B domain increases the dynamic range of PKC output because the signal does not saturate as readily using the lower affinity module and
allows cPKCs to signal at the plasma membrane as opposed to the Golgi.
(E) Dephosphorylation of activated PKC allows it to regain the exposed (open) conformation of unprimed PKC.
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without pretargeting by the Ca2+-regulated C2 domain (Dries
et al., 2007); therefore, cPKCs are directed to the plasma mem-
brane via the PIP2-sensing C2 domain where they can then find
DAG. In contrast, nPKCs, which have a higher affinity C1B
domain, translocate to the most DAG-enriched membrane, the
Golgi, without the need for pretargeting. Thus, masking of the
C1A domain in cPKCs tunes the affinity of PKC to reduce basal
signaling, increase the dynamic range of the PKC signal, and
determine the membrane to which PKC is recruited.
SIGNIFICANCE
We followed conformational transitions in living cells to
unveil a key regulatory mechanism in cell signaling: tuning
of ligand affinity by intramolecular conformational changes.
Specifically, we use FRET-based reporters in live cells to
showhowamultidomain signal transducer, PKC, undergoes
conformational transitions upon phosphorylation-induced
maturation that tune the affinity of its DAG-binding C1A and
C1B domains for optimal signaling. Importantly, we show
that these conformational transitions keep PKC inactive un-
der basal conditions, but allow ultrasensitivity in responses
to small changes in agonist-evoked levels of DAG. Confor-
mational rearrangements that optimize the dynamic range
of signaling will likely serve as a paradigm for signaling by
many other multimodule transducers. Our FRET-based
methods todepict thesechanges in livingcellsareapplicable
to the vast array of multimodule signal transducers.
EXPERIMENTAL PROCEDURES
Plasmid Constructs
C-terminally tagged rat PKCbII-YFP (Dries et al., 2007), rat PKCbII-RFP (Gould
et al., 2009), mouse PKCd-YFP (Wu-Zhang et al., 2012), DAGR, bovineChemistry & Biology 21,PKCa-HA, and membrane-targeted CFP were described previously (Violin
et al., 2003). Kinameleon was cloned into pcDNA3 as YFP-PKCbII-CFP and
Kinameleon-K371R was generated by QuikChange site-directed mutagenesis
(Stratagene). A C1A-C1B construct containing the N terminus of rat PKCbII
(residues 1–156) was subcloned into DAGR. Bovine YFP-PKCawas generated
by subcloning PKCa into pcDNA3with YFP at the N terminus. All mutants were
generated by QuikChange site-directed mutagenesis (Stratagene).
Antibodies and Materials
Themousemonoclonal anti-HA antibody (HA.11, clone 16B12) was purchased
from Covance, the mouse monoclonal anti-b-actin antibody (A2228) was pur-
chased from Sigma-Aldrich, and the mouse monoclonal anti-PKCb antibody
(610128) was from BD Transduction Laboratories. PDBu and 1,2-dioctanoyl-
sn-glycerol (DiC8) were obtained from Calbiochem. The 13 Hanks’ balanced
salt solution was purchased from Cellgro. All other materials and chemicals
were reagent grade.
Cell Culture, Transfection, and Immunoblotting
COS7 cells were maintained in DMEM (Cellgro) containing 5% or 10% fetal
bovine serum (GIBCO) and 1% penicillin/streptomycin (GIBCO) at 37C
in 5% CO2. MDCK cells were cultured in Dulbecco’s modified Eagle’s
medium/F-12 50/50 (Cellgro) containing 10% fetal bovine serum and 1%peni-
cillin/streptomycin. Transient transfection of COS7 was carried out using
the jetPRIME transfection reagent (PolyPlus Transfection) or the FuGENE 6
transfection reagent (Roche Applied Science) for 24 hr. MDCK cells were
transiently transected using PolyFect (QIAGEN) for 36 hr. Cells were lysed
in 50 mM Tris, pH 7.4, 1% Triton X-100, 50 mM NaF, 10 mM Na4P2O7,
100 mMNaCl, 5 mM EDTA, 1 mMNa3VO4, 1 mM phenylmethanesulfonylfluor-
ide, and 50 nM Okadaic acid. Whole cell lysates were analyzed with SDS-
PAGE and western blotting via chemiluminescence on a FluorChem imaging
system (Alpha Innotech).
FRET Imaging and Analysis
Cells were plated onto glass coverslips in 35 mm dishes, transfected with the
indicated constructs, and imaged in Hanks’ balanced salt solution supple-
mented with 1 mM CaCl2. CFP, YFP, and FRET images were acquired with
a 403 objective with a Zeiss Axiovert microscope (Carl Zeiss Microimaging)
using a MicroMax digital camera (Roper-Princeton Instruments) controlled
by MetaFluor software version 6.1r6 (Universal Imaging) as described
previously (Gallegos et al., 2006). Pseudocolor images were acquired at the459–469, April 24, 2014 ª2014 Elsevier Ltd All rights reserved 467
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Live Cell Imaging of PKC Conformational Changesindicated times before and after treatment with 200 nM PDBu and normalized
to the same minimum and maximum values. For the translocation experi-
ments, baseline images were acquired every 7 or 15 s for 3 or more minutes
before ligand addition. Because the maximal amplitude of translocation of
the mutants varied, possibly due to changes in the orientation or distance of
the fluorophores caused by differential folding of the kinase, the data were
normalized to the maximal amplitude of translocation for each cell. Normaliza-
tion was achieved by dividing by the average baseline FRET ratio, and then
scaled from 0% to 100% of maximal translocation using the equation: X =
(YYmin)/(YmaxYmin), where Y is normalized FRET ratio, Ymin is minimum value
of Y, and Ymax is maximum value of Y. Data from at least three different imaging
dishes were referenced around the ligand addition time point and the average
of these normalized values ± SEM were plotted and curve fitted. Curve fitting
was performed using Graph Pad Prism 6.0a (GraphPad Software). The half-
time of translocation was calculated by fitting the data to a nonlinear regres-
sion using a one-phase exponential association equation.
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